home / stock / adtx / adtx news

ADTX News and Press, ADiTx Therapeutics Inc. From 01/30/24

Stock Information
Company Name: ADiTx Therapeutics Inc.
Stock Symbol: ADTX
Market: NASDAQ
Website: aditxt.com
Menu
ADTX ADTX Quote ADTX Short ADTX News ADTX Articles ADTX Message Board
Get ADTX Alerts

News, Short Squeeze, Breakout and More Instantly...
ADTX - Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap(TM) and NeuroEEG(TM) for Telehealth and Tele-neurology Applications

The global EEG devices market was valued at $1.06 billion in 2022 and is anticipated to expand at a CAGR of 10.2% from 2023 to 2030 Aditxt, Inc. (“Aditxt” or the “Company”) (NASDAQ: ADTX), a company dedicated to discovering, developing, and deploying promisin...
ADTX - Aditxt files to sell 3.79M shares for holders

2024-01-18 16:37:30 ET More on Aditx Therapeutics Aditxt announces $6M private placement to fund its working capital Aditxt to acquire women’s health company Evofem Biosciences Seeking Alpha’s Quant Rating on Aditx Therapeutics Historical earnin...

ADTX - InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX), Subsidiary Pearsanta Announce Acquisition of MDNA Life Sciences Inc.'s Mitomic(TM) Testing Platform

Aditxt (NASDAQ: ADTX) , a company dedicated to discovering, developing and deploying promising health innovations, and its subsidiary Pearsanta Inc., have announced the acquisition of MDNA Life Sciences Inc.’s (“MDNA”) proprietary, early-disease and cancer-detection plat...

ADTX - Aditxt, Inc.'s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.'s Proprietary Mitomic(TM) Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million

This strategic acquisition positions Pearsanta for robust growth: expanding opportunities in women’s health, spanning endometriosis to ovarian cancer, and in men’s health starting with prostate cancer Aditxt, Inc. (“Aditxt” or the “Company”) (NA...
ADTX - Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has closed its previously announced private placement for the purchase and sale of an agg...

ADTX - NDRA, PYPD and TAOP among mid-day movers

2024-01-02 12:56:48 ET More on Mid-day movers & stocks. ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Endra Life Sciences Historical earnings da...

ADTX - Aditxt regains compliance with Nasdaq rule on minimum stockholders' equity

2024-01-02 08:46:55 ET More on Aditx Therapeutics Aditxt announces $6M private placement to fund its working capital Aditxt to acquire women’s health company Evofem Biosciences Seeking Alpha’s Quant Rating on Aditx Therapeutics Historical earnin...
ADTX - SXTC, CGA and JFBR among pre-market losers

2024-01-02 08:30:21 ET Losers: Corcept Therapeutics CORT -33% in patent battle with Teva . China SXT Pharmaceuticals ( SXTC ) -29% . Sentage Holdings ( SNTG ) -27% . China Green Agriculture ( CGA ) -23% . Aditxt ( ADTX ) -24% . ...

ADTX - Aditxt, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement

Aditxt, Inc. (“Aditxt” or “the Company”) (NASDAQ: ADTX), a company dedicated to discovering, developing, and deploying promising health innovations, today announced that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) Hearing Pane...

ADTX - Siyata Mobile (NASDAQ: SYTA) Enters 2024 in a Very Provocative Position

2024-01-02 07:18:36 ET Companies mentioned; Siyata Mobile (NASDAQ: SYTA), Aditxt (NASDAQ: ADTX), Cingulate Inc (NASDAQ: CING), C4 Therapeutics Inc. (NASDAQ: CCCC), Merck (NYSE: MRK), and Shattuck Labs (NASDAQ: STTK). DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- Siyata Mobi...
Previous 10 Next 10